SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-033646
Filing Date
2020-12-11
Accepted
2020-12-11 20:00:18
Documents
2
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8078
2 EX-24 DOCUMENT attachment1.htm EX-24 4895
  Complete submission text file 0000899243-20-033646.txt   14324
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address
Hansen Carl L. G. (Reporting) CIK: 0001834412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39781 | Film No.: 201384818